EX-25.1 16 b78349a2exv25w1.htm EX-25.1 exv25w1
Exhibit 25.1
Registration No. 333-158542
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM T-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY
OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) þ
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
(Exact name of trustee as specified in its charter)
     
Delaware   95-3571558
(State of incorporation   (I.R.S. employer
if not a U.S. national bank)   identification no.)
     
700 South Flower Street, Suite 500    
Los Angeles, California   90017
(Address of principal executive offices)   (Zip code)
Robert J. Sussman, Esq.
Legal Department
The Bank of New York Mellon Trust Company, National Association
One Wall Street
New York, NY 10286
(212) 635-1089
(Name, address and telephone number of agent for service)
 
INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of obligor as specified in its charter)
(See table of additional obligors on following page)
     
Delaware   04-3565120
(State of incorporation   (I.R.S. employer
if not a U.S. national bank)   identification no.)

 

 

     
51 Sawyer Road, Suite 200   02453
Waltham, Massachusetts   (Zip code)
(Address of principal executive offices)    
 
7.875% Senior Notes Due 2016
(Title of the indenture securities)
 

- 2 -

 

TABLE OF ADDITIONAL OBLIGORS
     Some or all of the following direct and indirect wholly owned domestic subsidiaries of Inverness Medical Innovations, Inc. are expected to guarantee the debt securities issued pursuant to the Indenture. The address, including zip code, and telephone number, including area code, of each of the co-obligors is 51 Sawyer Road, Suite 200, Waltham, Massachusetts, 02453, (781) 647-3900:
         
    State or other    
    jurisdiction of    
Exact name of additional registrant   incorporation or   I.R.S. Employer
as specified in its charter   organization   Identification Number
Alere Health, LLC
  Delaware   26-2564744
Alere Healthcare of Illinois, Inc.
  Georgia   58-2068880
Alere Health Improvement Company
  Delaware   23-2776413
Alere Health Systems, Inc.
  Delaware   22-3493126
Alere Medical, Inc.
  California   94-3238845
Alere NewCo, Inc.
  Delaware   27-2104833
Alere NewCo II, Inc.
  Delaware   27-2104868
Alere Wellology, Inc.
  Delaware   54-1776557
Alere Women’s and Children’s Health, LLC
  Delaware   58-2205984
Ameditech Inc.
  California   33-0859551
Applied Biotech, Inc.
  California   33-0447325
Binax, Inc.
  Delaware   20-2507302
Biosite Incorporated
  Delaware   33-0288606
Cholestech Corporation
  Delaware   94-3065493
First Check Diagnostics Corp.
  Delaware   20-8329751
First Check Ecom, Inc.
  Massachusetts   33-1026518
Free & Clear, Inc.
  Delaware   20-0231080
GeneCare Medical Genetics Center, Inc.
  North Carolina   56-1348485
Hemosense, Inc.
  Delaware   77-0452938
Alere US Holdings, LLC
  Delaware   26-0349667
Innovacon, Inc.
  Delaware   20-1100264
Instant Technologies, Inc.
  Virginia   54-1837621
Inverness Medical, LLC
  Delaware   26-0392649
Inverness Medical — Biostar Inc.
  Delaware   91-1929582
Inverness Medical Innovations North America, Inc.
  Delaware   26-1444559
Alere International Holding Corp.
  Delaware   20-0963463
Ischemia Technologies, Inc.
  Delaware   84-1489537
IVC Industries, Inc.
  Delaware   22-1567481
Kroll Laboratory Specialists, Inc.
  Louisiana   72-0846066
Laboratory Specialists of America, Inc.
  Oklahoma   73-1451065
Matria of New York, Inc.
  New York   58-1873062
Matritech, Inc.
  Delaware   26-1436477
New Binax, Inc.
  Delaware   36-4668096
New Biosite Incorporated
  Delaware   27-2104785
Ostex International, Inc.
  Washington   91-1450247
Quality Assured Services, Inc.
  Florida   59-3437644
Redwood Toxicology Laboratory, Inc.
  California   68-0332937
RMD Networks, Inc.
  Delaware   84-1581993
RTL Holdings, Inc.
  Delaware   20-4371685
Scientific Testing Laboratories, Inc.
  Virginia   54-1624514
Selfcare Technology, Inc.
  Delaware   04-3383533
Tapestry Medical, Inc.
  Delaware   20-0391730
Wampole Laboratories, LLC
  Delaware   37-1485678
ZyCare, Inc.
  North Carolina   56-1398496

- 3 -

 

1.   General information. Furnish the following information as to the trustee:
  (a)   Name and address of each examining or supervising authority to which it is subject.
     
Name   Address
Comptroller of the Currency — United States Department of the Treasury
  Washington, D.C. 20219
 
    
Federal Reserve Bank
  San Francisco, California 94105
 
    
Federal Deposit Insurance Corporation
  Washington, D.C. 20429
  (b)   Whether it is authorized to exercise corporate trust powers.
 
      Yes.
2.   Affiliations with Obligor.
 
    If the obligor is an affiliate of the trustee, describe each such affiliation.
 
    None.
 
16.   List of Exhibits.
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a 29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d).
  1. A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A., formerly known as The Bank of New York Trust Company, N.A. (Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121948 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152875 which is incorporated by reference).
 
  2.   A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed with Registration Statement No. 333-121948) which is incorporated by reference.
 
  3.   A copy of the authorization of the trustee to exercise corporate trust powers (Exhibit 3 to Form T-1 filed with Registration Statement No. 333-152875 which is incorporated by reference).
 
  4.   A copy of the existing by laws of the trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-152875 which is incorporated by reference).
 
  5.   Not applicable.

- 4 -

 

  6.   The consent of the trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-152875 which is incorporated by reference).
 
  7.   A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.
 
  8.   Not applicable.
 
  9.   Not applicable.

- 5 -

 

SIGNATURE
     Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of Boston, and State of Massachusetts, on the 15th day of April, 2010.
         
  THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
 		  
  By:   /s/ Raymond K. O’Neil  
    Name:   Raymond K. O’Neil  
    Title:   Senior Associate  
 

- 6 -

 

EXHIBIT 7
REPORT OF CONDITION
Consolidating domestic subsidiaries of
The Bank of New York Mellon Trust Company
in the state of CA at close of business on December 31, 2009
published in response to call made by (Enter additional information below)
 
 
Statement of Resources and Liabilities
             
        Dollar Amounts in Thousands
ASSETS
            
 
Cash and balances due from depository institutions:
            
Noninterest-bearing balances and currency and coin
         1,576  
Interest-bearing balances
         267  
Securities:
            
Held-to-maturity securities
         16  
Available-for-sale securities
         601,754  
Federal funds sold and securities purchased under agreements to resell:
            
Federal funds sold
         78,000  
Securities purchased under agreements to resell
         0  
Loans and lease financing receivables:
            
Loans and leases held for sale
         0  
Loans and leases, net of unearned income
   0        
LESS: Allowance for loan and lease losses
   0        
Loans and leases, net of unearned income and allowance
         0  
Trading Assets
         0  
Premises and fixed assets (including capitalized leases)
         11,186  
Other real estate owned
         0  
Investments in unconsolidated subsidiaries and associated companies
         2  
Direct and indirect investments in real estate ventures
         0  
Intangible assets:
            
Goodwill
         856,313  
Other intangible assets
         244,779  
Other assets
         154,682  
 
            
Total assets
         1,948,575  
 
            

 

REPORT OF CONDITION (Continued)
             
        Dollar Amounts in Thousands
LIABILITIES
           
 
Deposits:
            
In domestic offices
         532  
Noninterest-bearing
   532        
Interest-bearing
   0        
Federal funds purchased and securities sold under agreements to repurchase:
            
Federal funds purchased
         0  
Securities sold under agreements to repurchase
         0  
Trading liabilities
         0  
Other borrowed money (includes mortgage indebtedness and obligations under capitalized leases)
         268,691  
Subordinated notes and debentures
         0  
Other liabilities
         219,066  
Total liabilities
         488,289  
 
            
EQUITY CAPITAL
            
Bank Equity Capital
            
Perpetual preferred stock and related surplus
         0  
Common stock
         1,000  
Surplus (excludes all surplus related to preferred stock)
         1,121,520  
Retained earnings
         337,084  
Accumulated other comprehensive income
         682  
Other equity capital components
         0  
Total bank equity capital
         1,460,286  
Noncontrolling (minority) interest in consolidated subsidiaries
         0  
Total equity capital
         1,460,286  
 
            
Total liabilities and equity capital
         1,948,575  
 
            

We, the undersigned directors (trustees), attest to the correctness of the Reports of Condition and Income (including the supporting schedules) for this report date and declare that the Reports of Condition and Income have been examined by us and to the best of our knowledge and belief have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true and correct.
Director #1   Troy Kilpatrick, President
Director #2   Frank Sulzberger, Managing Director
Director #3   William Lindelof, Managing Director
/s/ Karen Bayz                                        
I, Karen Bayz, Chief Financial Officer
 
(Name, Title)
of the above named bank do hereby declare that this Report of Condition is true and correct to the best of my knowledge and belief.
         
     
  /s/ Troy Kilpatrick    
     
  /s/ Frank Sulzberger    
     
  /s/ William Lindelof